Trademark Overview
On Friday, March 13, 2026, a trademark application was filed for CARIS MOLECULAR TUMOR BOARD REPORT with the United States Patent and Trademark Office. The USPTO has given the CARIS MOLECULAR TUMOR BOARD REPORT trademark a serial number of 99701203. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 13, 2026. This trademark is owned by Caris MPI, Inc.. The CARIS MOLECULAR TUMOR BOARD REPORT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer using bioinformatics and artificial intelligence; providing medical information in the field of cancer based on molecular profiling, including next-generation sequencing (NGS) such as whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)
Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on molecular profiling, including next-generation sequencing (NGS) such as whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)
